DCPH

Deciphera Pharmaceuticals, Inc. Common Stock

Delisted

DCPH was delisted on the 10th of June, 2024.

161 hedge funds and large institutions have $1.43B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 52 increasing their positions, 52 reducing their positions, and 11 closing their positions.

Holders
161
Holders Change
+15
Holders Change %
+10.27%
% of All Funds
2.83%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
27
Increased
52
Reduced
52
Closed
11
Calls
$18.3M
Puts
$3.23M
Net Calls
+$15.1M
Net Calls Change
+$10.9M
Name Market Value Shares Shares
Change
Shares
Change %
RG
1
Redmile Group
California
$137M 4,031,521 -213,200 -5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$134M 3,936,385 +8,681 +0.2%
BlackRock
3
BlackRock
New York
$126M 3,694,905 +13,692 +0.4%
Franklin Resources
4
Franklin Resources
California
$109M 3,195,854 +139,641 +5%
O
5
OrbiMed
New York
$74.2M 2,183,143 -1,114,158 -34%
State Street
6
State Street
Massachusetts
$65.3M 1,920,920 -129,914 -6%
LGM
7
Logos Global Management
California
$62.9M 1,850,000 +750,000 +68%
ACH
8
ArrowMark Colorado Holdings
Colorado
$61.6M 1,812,710 +259,427 +17%
NLVP
9
New Leaf Venture Partners
New York
$41.1M 1,209,571
ACA
10
Avoro Capital Advisors
New York
$36.3M 1,068,000
SCM
11
Suvretta Capital Management
New York
$29.3M 862,126 +209,491 +32%
DM
12
Deerfield Management
New York
$27.7M 815,000 -528,560 -39%
PAMS
13
Pictet Asset Management (Switzerland)
Switzerland
$25.5M 751,098 +751,098 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$25.1M 738,758 -1,572 -0.2%
CS
15
Candriam SCA
Luxembourg
$24.1M 708,117
AC
16
Armistice Capital
New York
$23M 678,000 +206,000 +44%
CIBC Asset Management
17
CIBC Asset Management
Ontario, Canada
$18.6M 547,084 +259 +0%
BNP Paribas Asset Management
18
BNP Paribas Asset Management
France
$16.7M 492,512 -324 -0.1%
Invesco
19
Invesco
Georgia
$16M 470,767 +56,452 +14%
SHI
20
SV Health Investors
Massachusetts
$15.3M 449,951
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$15.3M 449,099 -70,177 -14%
Goldman Sachs
22
Goldman Sachs
New York
$14.7M 432,983 +17,769 +4%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$13.9M 408,354 -13 -0%
Janus Henderson Group
24
Janus Henderson Group
United Kingdom
$13.8M 407,237 +109 +0%
Northern Trust
25
Northern Trust
Illinois
$13.6M 400,960 -23,379 -6%